Send to:

Choose Destination

Links from Books

Screening for chronic obstructive pulmonary disease using spirometry : summary of the evidence for the U.S. Preventive Services Task Force

Lin, Kenneth, author
Watkins, Bradley, author
Johnson, Tamara, active 2008, author
Rodriguez, Joy Anne, author
Barton, Mary B, author
United States Agency for Healthcare Research and Quality, issuing body
US Preventive Services Task Force
Screening for chronic obstructive pulmonary disease using spirometry : summary of the evidence for the U.S. Preventive Services Task ForceĀ / investigators, Kenneth Lin, Bradley Watkins, Tamara Johnson, Joy Anne Rodriguez, Mary B. Barton ; Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.
Evidence syntheses ; no. 59
[AHRQ publication] ; no. 08-05113-EF-1
Country of Publication:
United States
Rockville (MD) : Agency for Healthcare Research and Quality (US), March 2008.
1 online resource.
Electronic Links:
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States. Fewer than half of the estimated 24 million Americans with airflow obstruction have received a COPD diagnosis, and diagnosis often occurs in advanced stages of the disease. PURPOSE: To summarize the evidence on screening for COPD using spirometry for the U.S. Preventive Services Task Force (USPSTF). DATA SOURCES: English-language articles identified in PubMed and the Cochrane Library through January 2007, recent systematic reviews, expert suggestions, and reference lists of retrieved articles. STUDY SELECTION: Explicit inclusion and exclusion criteria were used for each of the 8 key questions on benefits and harms of screening. Eligible study types varied by question. Data Extraction: Studies were reviewed, abstracted, and rated for quality by using predefined USPSTF criteria. DATA SYNTHESIS: Pharmacologic treatments for COPD reduce acute exacerbations in patients with severe disease. However, severe COPD is uncommon in the general U.S. population. Spirometry has not been shown to independently improve smoking cessation rates. Potential harms from screening include false-positive results and adverse effects from subsequent unnecessary therapy. Data on the prevalence of airflow obstruction in the U.S. population were used to calculate projected outcomes from screening groups defined by age and smoking status. LIMITATION: No studies provide direct evidence on health outcomes associated with screening for COPD. CONCLUSION: Screening for COPD using spirometry is likely to identify a predominance of patients with mild to moderate airflow obstruction who would not experience additional health benefits if labeled as having COPD. Hundreds of patients would need to undergo spirometry to defer a single exacerbation.
Comparative Effectiveness Research
Mass Screening/adverse effects
Pulmonary Disease, Chronic Obstructive/diagnosis*
United States
Publication Type(s):
Title form HTML header.
Includes bibliographical references.
Issued also in print.
Description based on version viewed Nov. 4, 2013.
101618103 [Book]

Supplemental Content

Loading ...
Support Center